PERICYTES AS TARGETS IN HEREDITARY HEMORRHAGIC TELANGIECTASIA

FierceBiotechBeOne signs $2B deal for option on preclinical trispecific antibody from China’s Huahui

Cytiva (Google News)Rockwell Automation and Cytiva launch Figurate SCADA system to eliminate digital bottlenecks in biopharmaceutical manufacturing - Manufacturing Chemist

Endpoints News礼来公司第一季度财报悬而未决：减肥药销售细节缺失受关注

Endpoints News研发15强：药企巨头如何投入、赢取与失落于药物研发之路

Endpoints News诺华揭幕北卡罗来纳州工厂，作为230亿美元美国扩张计划的最后新建项目

FierceBiotechGSK对Alector的7亿美元押注失败，阿尔茨海默症药物二期试验未达标

10x Genomics News10x Genomics Inc (HAM:1KJ) Stock Earnings Transcripts - GuruFocus

FierceBiotechAvalyn携3亿美元超额募集赴纳斯达克IPO，推进改良型呼吸药物研发

FierceBiotech阿斯利康以2500万美元从Pinetree获得临床前EGFR降解剂

Novo Nordisk诺和诺德的GLP-1药物优势在礼来临床试验胜利后是否正在减弱？

Siemens Healthineers西门子医疗：诊断业务以60亿欧元退出，股价触底后即将进行分拆

BioPharma DiveAvalyn 寻求更好的肺部药物，在IPO中融资3亿美元